[go: up one dir, main page]

FI91711B - Menetelmä monoklonaalisten anti-lipidi A-vasta-aineiden valmistamiseksi ja niiden käyttö gram-negatiivisten bakteerien määrityksessä - Google Patents

Menetelmä monoklonaalisten anti-lipidi A-vasta-aineiden valmistamiseksi ja niiden käyttö gram-negatiivisten bakteerien määrityksessä

Info

Publication number
FI91711B
FI91711B FI852380A FI852380A FI91711B FI 91711 B FI91711 B FI 91711B FI 852380 A FI852380 A FI 852380A FI 852380 A FI852380 A FI 852380A FI 91711 B FI91711 B FI 91711B
Authority
FI
Finland
Prior art keywords
lipid
gram
determination
preparation
monoclonal antibodies
Prior art date
Application number
FI852380A
Other languages
English (en)
Swedish (sv)
Other versions
FI91711C (fi
FI852380A0 (fi
FI852380L (fi
Inventor
Jr Warren C Bogard
Patrick C Kung
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of FI852380A0 publication Critical patent/FI852380A0/fi
Publication of FI852380L publication Critical patent/FI852380L/fi
Application granted granted Critical
Publication of FI91711B publication Critical patent/FI91711B/fi
Publication of FI91711C publication Critical patent/FI91711C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/50—Lipopolysaccharides; LPS
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal
    • Y10S530/865—Human

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI852380A 1983-10-14 1985-06-14 Menetelmä monoklonaalisten anti-lipidi A-vasta-aineiden valmistamiseksi ja niiden käyttö gram-negatiivisten bakteerien määrityksessä FI91711C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54211183 1983-10-14
US06/542,111 US5179018A (en) 1983-10-14 1983-10-14 Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US8401643 1984-10-12
PCT/US1984/001643 WO1985001659A1 (en) 1983-10-14 1984-10-12 Monoclonal antibodies against endotoxin of gram-negative bacteria

Publications (4)

Publication Number Publication Date
FI852380A0 FI852380A0 (fi) 1985-06-14
FI852380L FI852380L (fi) 1985-06-14
FI91711B true FI91711B (fi) 1994-04-29
FI91711C FI91711C (fi) 1994-08-10

Family

ID=24162382

Family Applications (1)

Application Number Title Priority Date Filing Date
FI852380A FI91711C (fi) 1983-10-14 1985-06-14 Menetelmä monoklonaalisten anti-lipidi A-vasta-aineiden valmistamiseksi ja niiden käyttö gram-negatiivisten bakteerien määrityksessä

Country Status (15)

Country Link
US (1) US5179018A (fi)
EP (2) EP0481970A3 (fi)
JP (1) JPH0794479B2 (fi)
AU (1) AU577554B2 (fi)
DE (1) DE3486146T2 (fi)
DK (1) DK270285A (fi)
ES (1) ES8608170A1 (fi)
FI (1) FI91711C (fi)
GR (1) GR80621B (fi)
IE (1) IE60643B1 (fi)
IT (1) IT1221077B (fi)
NO (1) NO852426L (fi)
PT (1) PT79351B (fi)
WO (1) WO1985001659A1 (fi)
ZA (1) ZA847944B (fi)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
IE940698L (en) * 1984-04-05 1985-10-05 Univ Missouri Vaccine and serum for endotoxin associated disease and method of preparing same as well as to methods of immunization and treatment of such disease and to a detoxified endotoxin and bacterial mutant
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
FI853395L (fi) * 1984-09-05 1986-03-06 Cetus Corp Monoklonala antikroppar som blockerar gram-negativ bakterieendotoxin.
JPS61130300A (ja) * 1984-11-27 1986-06-18 ザ　ボ−ド　オブ　トラステイ−ズ　オブ　ザ　レランド　スタンフオ−ド　ジユニア　ユニバ−シテイ ヒトモノクロ−ナル抗体
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
DE3685700T2 (de) * 1985-03-11 1993-03-11 Teijin Ltd E87ag-antigen des pseudomonas aeruginosa, monoklonale antikoerper dagegen und hybridom.
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
JPS63500035A (ja) * 1985-06-06 1988-01-07 ジエネテイツク　システムズ　コ−ポレイシヨン プソイドモナス　アエルギノサ　外毒素ａに対する保護用ヒトモノクロ−ナル抗体
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
EP0494085A1 (en) 1985-09-27 1992-07-08 The Regents Of The University Of California Monoclonal antibodies binding determinants of gram negative bacteria
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
US5179001A (en) * 1985-09-27 1993-01-12 The Regents Of The University Of California Detection and monitoring of chronic and gram-negative infection
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
DE3745019C2 (de) * 1986-02-07 1998-01-29 Genetic Systems Corp Kreuz-schützende monoklonale Humanantikörper
ZA87863B (en) * 1986-02-07 1987-09-30 Genetic Systems Corp Cross-protective human monoclonal antibody compositions
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
ES2009365A6 (es) * 1986-04-24 1989-09-16 Univ California Procedimiento de otencion de anticuerpos monoclonales para bacterias gram-negativas.
EP0256713A3 (en) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutic human antipseudomonas aeruginosa antibodies
FR2606421B1 (fr) * 1986-11-12 1990-01-26 Roussel Uclaf Anticorps monoclonaux antigram (-) procede de preparation et applications
IE873057L (en) * 1986-11-13 1988-05-13 Tretorn Ab Compositions and method for treatment of cancer using¹monoclonal antibody against gd3 ganglioside together eith¹il-2
ZA878610B (en) * 1986-11-20 1989-06-28 Minnesota Mining & Mfg Method for the evaluation of oral microbes
US4870158A (en) * 1987-01-05 1989-09-26 University Of Pittsburgh Of The Commonwealth System Of Higher Education Polymyxin lipopolysaccharide antigen and associated method
JPH0222295A (ja) * 1987-01-05 1990-01-25 Univ Pittsburgh ポリミキシンアガロースリポ多糖抗原及びこれに関連する方法
GB2218703B (en) * 1988-05-10 1992-10-28 Sumitomo Chemical Co Human monoclonal antibody to p.aeruginosa: its production and use
US5766947A (en) * 1988-12-14 1998-06-16 Astra Ab Monoclonal antibodies reactive with an epitope of a Vβ3.1 variable region of a T cell receptor
DE3843784A1 (de) * 1988-12-24 1990-06-28 Battelle Institut E V Verfahren zum nachweis von gramnegativen mikroorganismen sowie hierfuer geeignete dna-proben und antikoerper
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock
US5650275A (en) * 1990-06-11 1997-07-22 Nexstar Pharmacueticals Inc Target detection method using spectroscopically detectable nucleic acid ligands
US5449619A (en) * 1992-04-16 1995-09-12 Sybron Chemical Holdings, Inc. Drain opener formulation
US5739132A (en) * 1992-07-02 1998-04-14 Tanabe Seiyaku Co., Ltd. Pyridazinone derivatives and processes for preparing the same
US5496700A (en) * 1993-08-06 1996-03-05 The United States Of America As Represented By The Secretary Of The Navy Optical immunoassay for microbial analytes using non-specific dyes
CA2138812A1 (en) * 1993-12-28 1995-06-29 Akihiko Ishida Indane derivative and processes for preparing the same
US5807694A (en) * 1995-09-07 1998-09-15 Economic Innovation And Technology Council, University Of Manitoba Detection of salmonella enteritidis and other pathogenic microorganisms and monoclonal antibody useful therefor
CA2241467A1 (en) * 1996-01-16 1997-07-24 Jian-Er Lin Cleaner and sanitizer formulation
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
US6790661B1 (en) * 1999-07-16 2004-09-14 Verax Biomedical, Inc. System for detecting bacteria in blood, blood products, and fluids of tissues
WO2004024099A2 (en) * 2002-04-02 2004-03-25 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
US20080114212A1 (en) 2006-10-10 2008-05-15 General Electric Company Detecting surgical phases and/or interventions
DE102005002969A1 (de) * 2005-01-21 2006-08-03 Profos Ag Verfahren zum Nachweis und zur Entfernung von Endotoxin
GB0621452D0 (en) 2006-10-27 2006-12-06 Ucl Business Plc Therapy for liver disease
WO2013049596A2 (en) * 2011-09-30 2013-04-04 The Penn State Research Foundation Rapid, specific and sensitive immunoassays for the detection of highly variable gram negative bacterial antigens
EP2617833A1 (en) * 2012-01-18 2013-07-24 Centre National de la Recherche Scientifique (CNRS) A method for specifically detecting living bacteria
SG11201900027XA (en) * 2016-08-05 2019-02-27 Medimmune Llc Anti-o2 antibodies and uses thereof
SG11201903063UA (en) 2016-10-19 2019-05-30 Medimmune Llc Anti-o1 antibodies and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451570A (en) * 1981-03-26 1984-05-29 The Regents Of The University Of California Immunoglobulin-secreting human hybridomas from a cultured human lymphoblastoid cell line
US4443549A (en) * 1981-10-19 1984-04-17 Molecular Genetics, Inc. Production of monoclonal antibodies against bacterial adhesins
US4455296A (en) * 1982-02-02 1984-06-19 Board Of Regents, The University Of Texas System Hybrid cell lines producing monoclonal antibodies directed against Haemophilus influenzae
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
DE3484773D1 (de) * 1983-05-06 1991-08-08 Velos Group Mit endotoxinkern reaktionsfaehige monoklonale antikoerper.
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
FI853395L (fi) * 1984-09-05 1986-03-06 Cetus Corp Monoklonala antikroppar som blockerar gram-negativ bakterieendotoxin.
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria

Also Published As

Publication number Publication date
IT8468015A0 (it) 1984-10-15
NO852426L (no) 1985-06-14
WO1985001659A1 (en) 1985-04-25
JPS61500355A (ja) 1986-03-06
PT79351A (en) 1984-11-01
DK270285A (da) 1985-08-13
EP0160670B1 (en) 1993-05-12
PT79351B (en) 1986-09-08
FI91711C (fi) 1994-08-10
ZA847944B (en) 1985-11-27
EP0160670A1 (en) 1985-11-13
FI852380A0 (fi) 1985-06-14
IE842625L (en) 1985-04-24
ES536721A0 (es) 1986-06-01
DK270285D0 (da) 1985-06-14
IT1221077B (it) 1990-06-21
AU577554B2 (en) 1988-09-29
ES8608170A1 (es) 1986-06-01
AU3550284A (en) 1985-05-07
JPH0794479B2 (ja) 1995-10-11
DE3486146T2 (de) 1993-12-09
FI852380L (fi) 1985-06-14
US5179018A (en) 1993-01-12
EP0481970A2 (en) 1992-04-22
EP0481970A3 (en) 1992-09-30
GR80621B (en) 1985-02-18
DE3486146D1 (de) 1993-06-17
IE60643B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
FI91711B (fi) Menetelmä monoklonaalisten anti-lipidi A-vasta-aineiden valmistamiseksi ja niiden käyttö gram-negatiivisten bakteerien määrityksessä
BR8304137A (pt) Tubulacao flangeada revestida com plastico e metodo para sua preparacao
GB2111676B (en) Device and method for determining the presence of antigens or antibodies
AU529210B3 (en) Monoclonal antibody in occult blood diagnosis
FI892900A (fi) Menetelmä ja laitteisto laminoitujen materiaalien valmistamiseksi
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
DK234785A (da) Immunanalyse for serumantistoffer
IT1199117B (it) Metodo per saggiare sostanze immuno reattive
FI870502A0 (fi) Menetelmä ristisuojaavien ihmisen monoklonaalisten vasta-aineiden valmistamiseksi ja vasta-ainetta tuottava solulinja
AU3529889A (en) Specific cea-family antigens, antibodies specific and their methods of use
NO170691C (no) Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav
GB2146351B (en) Monoclonal antibody
FR2606421B1 (fr) Anticorps monoclonaux antigram (-) procede de preparation et applications
EP0119528A3 (en) Monoclonal antibodies to human renal cancer antigens and method
DK717888D0 (da) Monoklonale antistoffer
PT86643A (pt) Method for measuring anti-dna antibodies
DK86382A (da) Antistoffer mod proteiner
KR850004418A (ko) 편광필름 및 그의 제조방법
AU546797B2 (en) Monoclonal antibodies against tumor antigens and method
DK494084D0 (da) Hybridoma, monokloniske antistoffer frembragt hermed og diagnosemetode under anvendelse af disse
FI893333A0 (fi) Menetelmä ja reagenssi vasta-aineiden määrittämiseksi
DK325183D0 (da) Mumane monoclonale antistoffer og lymfokiner
GB8306617D0 (en) Specific antibody
ATA244883A (de) Haltevorrichtung zur hueftuntersuchung mit haltevorrichtung zur hueftuntersuchung mit ultraschall ultraschall
GB2058083B (en) Composition and method for determining antibody

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: CENTOCOR, INC.